• Home
  • News
    • Editorial
    • MD(e)B(unker)
    • Related Researches
      • Di Bella's Foundation
      • 1960-1969
      • 1970-1979
      • 1980-1989
      • 1990-1999
      • 2000-2009
      • 2010-2019
      • 2020-2029
    • Science news
    • Scientific Documentation
  • About us...
    • Biography
    • Bibliography
  • The Method
    • Di Bella's Method!
    • 1998 Trial!
  • Media
    • Video Publications
    • News-PapersNews-Papers
      • Press
    • TestimonialTestimonial
      • Testimonies
    • Video GalleryVideo Gallery
      • Congresses
      • Video Testimonies
      • TV & C.
  • Case History
    • Medical reports
      • Lung
      • Lymphomas
        • Non-Hodgkin Lymphomas
        • Hodgkin Lymphomas
      • Mediastinum
      • Mesothelioma
      • Myeloma
      • Pancreas
      • Scientific Publications
  • F.A.Q.
  • Useful Links
    • User Side
      • Vademecum
    • CouponChief - Resources for Cancer Patients
  • Contact Us
Home page   News   Related Researches   2010-2019  
Title Created Date
Inhibition of U-87 MG glioblastoma by AN-152 (AEZS-108), a targeted cytotoxic analog of luteinizing hormone-releasing hormone 04 March 2015
Induction of cell differentiation and promotion of endocan gene expression in stomach cancer by melatonin 04 March 2015
Individual variations in serum melatonin levels through time: implications for epidemiologic studies 03 March 2015
Immunohistochemical expression of somatostatin receptor subtypes 2 and 5 in colorectal cancer 03 March 2015
Cytochromes p450 and skin cancer: role of local endocrine pathways 24 February 2015
Insulin-like growth factor-I inhibition with pasireotide decreases cell proliferation and increases apoptosis in pre-malignant lesions of the breast: a phase 1 proof of principle trial 17 February 2015
Merckel cell carcinoma of the skin treated with somatostatin analogue and mTOR inhibitor exhausted after primary surgery, adjuvant radiotherapy and palliative chemotherapy 13 February 2015
Health outcomes of vitamin D. Part II. Role in prevention of diseases 13 February 2015
Health outcomes of vitamin D. Part I. characteristics and classic role 13 February 2015
GEP-NETs update: Biotherapy for neuroendocrine tumours 12 February 2015
Display # 

Page 145 of 171

  • Start
  • Prev
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • Next
  • End

Search

Follow us...

Latest

  • Tumor-associated macrophages facilitate oral squamous cell carcinomas migration and invasion by MIF/NLRP3/IL-1β circuit: A crosstalk interrupted by melatonin
  • Extracellular Matrix in Synthetic Hydrogel-Based Prostate Cancer Organoids Regulate Therapeutic Response to EZH2 and DRD2 Inhibitors
  • Impaired vitamin D signaling reveals neutrophils as key drivers of prostate cancer dissemination
  • Melatonin attenuates bone cancer pain via the SIRT1/HMGB1 pathway
  • Pretreatment with melatonin protects against cyclophosphamide-induced oxidative stress and renal damage in mice
  • Melatonin Pharmacological Blood Levels Increase Total Antioxidant Capacity in Critically Ill Patients
  • A Review of Biological and Pharmacological Actions of Melatonin: Oxidant and Prooxidant Properties
  • Melatonin as Antioxidant Under Pathological Processes
  • Pharmacological utility of melatonin in reducing oxidative cellular and molecular damage
  • Melatonin as antioxidant, geroprotector and anticarcinogen
  • The potential therapeutic effects of melatonin on breast cancer: An invasion and metastasis inhibitor
  • Does the use of melatonin overcome drug resistance in cancer chemotherapy?
  • Melatonin and cancer: From the promotion of genomic stability to use in cancer treatment
  • Melatonin as a Therapeutic Agent for the Inhibition of Hypoxia-Induced Tumor Progression: A Description of Possible Mechanisms Involved
  • Modulation of apoptosis by melatonin for improving cancer treatment efficiency: An updated review
  • Multifaceted Role of Vitamin D in Breast Cancer: A Systematic Review of Genetic and Pathway-Based Mechanisms
  • Multifaceted roles of melatonin in oncology: an insight into its therapeutic potential in cancer management
  • Nocturnal Melatonin Deficiency in Colorectal Cancer: Independent Predictive Value Beyond Sleep Quality

Most Read

  • The Di Bella Method (DBM)
  • About melatonin - 1996
  • All-trans-retinoic acid and cancer
  • Biography
  • The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
  • Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
  • Somatostatin in oncology, the overlooked evidences
  • Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
  • How effective is chemo therapy?
  • Bibliography
  • Complete objective response to biological therapy of plurifocal breast carcinoma
  • Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
  • Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
  • Vademecum
  • Frequently Asked Questions
  • Declaration recommends eliminate the use of Impact factor for research evaluation
  • Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
  • Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer